Clinical trial

Smart Watch Insights for Prevention of Exacerbations and Enhance Rehabilitation - Movement Study

NCT06011356

Drugs and interventions used in this trial

1 registered

These interventions are listed by ClinicalTrials.gov. An RxNorm link indicates a mapped medicine record; the registry name alone is not proof of a specific branded formulation.

Search this trial's interventions

DEVICE · Unmapped registry intervention Smartwatch Find medicine records · Find other trials using this name

Study at a glance

Registry-backed

Smart Watch Insights for Prevention of Exacerbations and Enhance Rehabilitation - Movement Study

Design: OBSERVATIONAL · Status: ACTIVE NOT RECRUITING · Phase: Not specified

Read study objectives, eligibility and outcome measures at ClinicalTrials.gov

StatusACTIVE_NOT_RECRUITING

Study typeOBSERVATIONAL

Start date2023-08-30

PhaseN/A

Conditions

Cardiovascular Diseasesunresolved

Non-Alcoholic Fatty Liver Diseaseverified · MONDO: metabolic dysfunction-associated steatotic liver disease

Respiratory Diseaseverified · MONDO: respiratory system disorder

Diabetesverified · MONDO: diabetes mellitus

Interventions

SmartwatchDEVICE

Sponsors & collaborators

Imperial College Londonlead sponsor

Registry source

Open the source record to verify current eligibility, contacts, locations and registry updates.

Open NCT06011356 on ClinicalTrials.gov ↗

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.